Pulmonary Function Testing Systems Market Synopsis

Pulmonary Function Testing Systems Market Size Was Valued at USD 141.8 Million in 2023, and is Projected to Reach USD 282.99 Million by 2032, Growing at a CAGR of 7.98% From 2024-2032.

Pulmonary function tests are non-invasive tests that determine how well the lungs work. The tests measure lung volume, gas exchange, and rates of flow. This test helps physicians and healthcare workers to diagnose and decide the treatment of lung disorders.

• Lungs perform the function of the pulmonary. This involves breathing in air through the nasal passages leading to the lungs and taking in oxygen from the blood that travels to other parts of the body and exhaling carbon dioxide as waste through the nasal passages.
• People are given a number of tests to check how well their lungs are working. These are done with pulmonary function testing equipment. Tests can be done for two reasons. First, if the airway is blocked or obstructed. Second, when the absorption of oxygen in the blood is limited or reduced.
• The key manufacturers of pulmonary function testing systems are focused on partnership, acquisition, and collaboration to boost market growth. For instance, add Medical Technologies announced its new partnership with Biomedix, a provider of front-line diagnostic solutions for delivering value-based care. Biomedix offers various platforms that centralize data for analyzing population health across multiple chronic conditions, including COPD.

The Pulmonary Function Testing Systems Market Trend Analysis

Increasing Prevalence of The Lung-Related Disorder

• The increasing prevalence of lung cancer and lung-related disorders boosts the market growth. For instance, according to world cancer research world fund international, lung cancer is the second-most common cancer around the world. There were more than 2.2 million new cases of lung cancer in 2020. Moreover, an increase in air pollution which leads to breathing problems drives the market growth.
• Smoking and drinking habits cause lung cancer so the demand for pulmonary function equipment is increasing and it’s a major factor that drives the market growth. For instance, according to Statista, the age-standardized incidence rate of lung cancer among males around the world was 31.5 per 100,000 population. In 2020 the incidence rate of lung cancer among males was highest in Polynesia.
• The growing demand for minimally invasive tests to design an appropriate method of lung testing disease and increasing in the rate of mortality boosts the market growth in the upcoming years. Additionally, the increase in the geriatric population and people's awareness is also driving the demand for portable lung function testing devices as they can be easily used in home healthcare.

Technological Advancement and Innovation in Technology          

• The excessive consumption of tobacco in the form of cigarettes and the use of this test to ensure lung health and the infection-free nature of the body's airways are driving the growth of the pulmonary function testing market.
• As awareness of the systematic examination of a patient's lung health through chest x-rays, physical tests, arterial blood gas analysis, and examination of the patient's habits and medical history has increased, so has a concern about lung damage that can affect normal lung function. Life and the need to limit their impact and severity are also influencing the pulmonary function testing market. In addition, improvements in healthcare infrastructure, growth in research and development, and growth in healthcare costs are positively affecting the pulmonary function testing market growth.
• Technological advancements and technological innovations will create more growth opportunities for pulmonary function testing system market players during the forecast period. Life expectancy has increased, which means that there are a large number of elderly people who need medical care. Diseases such as lung cancer, pulmonary congestion, and asthma are more common in the elderly. Such factors provide additional growth opportunities for the market.

Segmentation Analysis of The Pulmonary Function Testing Systems Market

Pulmonary Function Testing Systems market segments cover the Type, Test, Application, and End User. By End Users, the hospital segment is anticipated to dominate the Market Over the Forecast period.

• The segmental growth is the result of an increase in the number of patients with COPD and asthma visiting hospitals. Moreover, the segment is anticipated to rise in the upcoming years due to hospitals' increasing usage of comprehensive systems for patient diagnosis. The category for physician groups is anticipated to grow fast throughout the forecast period.
• The rise in the prevalence of chronic respiratory disorders, the increased focus of market leaders on developing portable systems for hospitals, and an increase in the use of these systems in clinics are all factors that drive the segment's growth. For instance, in August 2019, Ruby Hall in Pune, India, announced the installation of the CareFusion-produced Vyntus Body pulmonary function test system. Moreover, the increased number of patients visiting hospitals for the diagnosis of lung disorders boosts the market growth in the upcoming years.

Regional Analysis of The Pulmonary Function Testing Systems Market

North America is Expected to Dominate the Pulmonary Function Testing Systems Market Over the Forecast period.

• In North America advanced medical infrastructure and the high disposable income of consumers increase the growth in pulmonary function testing systems can boost the market growth.  In this region well, developed healthcare infrastructure as well as the rising prevalence of pulmonary disorders and respiratory diseases drives the market growth in this region.
• North America due to increasing research and development facilities for approval and development of novel drug therapies as well as rising demand for advanced medical devices for treatment boosts the market growth. Various government policies support the purchase of advanced pulmonary function testing and increasing genetic diseases boost the market growth. Also, technologically advanced products offering more features in function testing systems are the driving factor in this region. Additionally, an increase in the per capita healthcare expenditure with increasing hospital admissions drives the growth of the pulmonary function testing system market in this region in the upcoming years.

Top Key Players Covered in The Pulmonary Function Testing Systems Market

• MGC Diagnostics Corporation (US)
• Morgan Scientific Inc. (US)
• Omron Healthcare Inc(Japan)
• Cosmed Srl (Italy)
• Ganshorn Medizin Electronic (Germany)
• ndd Medizintechnik AG (Switzerland)
• Schiller AG (Switzerland)
• Vyaire Medical, Inc (US)
• Minato Holdings Inc. (Japan)
• Eco Medics Ag (Switzerland)
• Chest M.I., Inc (Japan)
• Koninklijke Philips N.V.  (Netherlands)
• PulmOne Advanced Medical Devices (Israel)
• KoKo PFT (US), and Other Major Players.

Key Industry Developments in the Pulmonary Function Testing Systems Market

• In March 2023, Vitalograph, a respiratory diagnostic devices manufacturer, announced the launch of the VitaloPFT Pulmonary Function Testing Series at the annual Arab Health Exhibition in Dubai. The product was launched with an aim for use in secondary care.
• January 2023, CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., expanded its expertise in pulmonary disease by acquiring MGC Diagnostics Corporation. The acquisition allowed CAIRE to strengthen its position in the respiratory care market. This strategic move aligned with the company's goal to enhance its product offerings and provide advanced solutions for diagnosing and treating pulmonary conditions.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Test
 3.3 By Application
 3.4 By End Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Pulmonary Function Testing Systems Market by Type
 5.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 5.2 Pulmonary Function Testing Systems Market Overview
 5.3 Portable PFT Systems
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size ( 2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Portable PFT Systems: Geographic Segmentation
 5.4 Complete PFT Systems
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size ( 2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Complete PFT Systems: Geographic Segmentation

Chapter 6: Pulmonary Function Testing Systems Market by Test
 6.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 6.2 Pulmonary Function Testing Systems Market Overview
 6.3 Gas Exchange Testing
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size ( 2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Gas Exchange Testing: Geographic Segmentation
 6.4 Oxygen Titration Test
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size ( 2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Oxygen Titration Test: Geographic Segmentation
 6.5 Spirometry
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size ( 2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Spirometry: Geographic Segmentation
 6.6 Lung Volume
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size ( 2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Lung Volume: Geographic Segmentation
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size ( 2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation

Chapter 7: Pulmonary Function Testing Systems Market by Application
 7.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 7.2 Pulmonary Function Testing Systems Market Overview
 7.3 Restrictive Lung Disease
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size ( 2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Restrictive Lung Disease: Geographic Segmentation
 7.4 Chronic Obstructive Pulmonary Disease
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size ( 2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Chronic Obstructive Pulmonary Disease: Geographic Segmentation
 7.5 Asthma
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size ( 2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Asthma: Geographic Segmentation
 7.6 Other
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size ( 2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Other: Geographic Segmentation

Chapter 8: Pulmonary Function Testing Systems Market by End Users
 8.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 8.2 Pulmonary Function Testing Systems Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size ( 2017-2032F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Geographic Segmentation
 8.4 Clinical Laboratories
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size ( 2017-2032F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Clinical Laboratories: Geographic Segmentation
 8.5 Diagnostics Laboratories
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size ( 2017-2032F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Diagnostics Laboratories: Geographic Segmentation
 8.6 Other
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size ( 2017-2032F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Other: Geographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Pulmonary Function Testing Systems Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Heat Map Analysis
  9.1.5 Pulmonary Function Testing Systems Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Pulmonary Function Testing Systems Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 MGC DIAGNOSTICS CORPORATION
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 MORGAN SCIENTIFIC INC.
 9.4 OMRON HEALTHCARE INC
 9.5 COSMED SRL
 9.6 GANSHORN MEDIZIN ELECTRONIC
 9.7 NDD MEDIZINTECHNIK AG
 9.8 SCHILLER AG
 9.9 VYAIRE MEDICAL INC
 9.10 MINATO HOLDINGS INC.
 9.11 ECO MEDICS AG
 9.12 CHEST M.I. INC
 9.13 KONINKLIJKE PHILIPS N.V.
 9.14 PULMONE ADVANCED MEDICAL DEVICES
 9.15 KOKO PFT
 9.16 OTHER MAJOR PLAYERS

Chapter 10: Global Pulmonary Function Testing Systems Market Analysis, Insights and Forecast,  2017-2032
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Portable PFT Systems
  10.2.2 Complete PFT Systems
 10.3 Historic and Forecasted Market Size By Test
  10.3.1 Gas Exchange Testing
  10.3.2 Oxygen Titration Test
  10.3.3 Spirometry
  10.3.4 Lung Volume
  10.3.5 Others
 10.4 Historic and Forecasted Market Size By Application
  10.4.1 Restrictive Lung Disease
  10.4.2 Chronic Obstructive Pulmonary Disease
  10.4.3 Asthma
  10.4.4 Other
 10.5 Historic and Forecasted Market Size By End Users
  10.5.1 Hospitals
  10.5.2 Clinical Laboratories
  10.5.3 Diagnostics Laboratories
  10.5.4 Other

Chapter 11: North America Pulmonary Function Testing Systems Market Analysis, Insights and Forecast,  2017-2032
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Portable PFT Systems
  11.4.2 Complete PFT Systems
 11.5 Historic and Forecasted Market Size By Test
  11.5.1 Gas Exchange Testing
  11.5.2 Oxygen Titration Test
  11.5.3 Spirometry
  11.5.4 Lung Volume
  11.5.5 Others
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Restrictive Lung Disease
  11.6.2 Chronic Obstructive Pulmonary Disease
  11.6.3 Asthma
  11.6.4 Other
 11.7 Historic and Forecasted Market Size By End Users
  11.7.1 Hospitals
  11.7.2 Clinical Laboratories
  11.7.3 Diagnostics Laboratories
  11.7.4 Other
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Pulmonary Function Testing Systems Market Analysis, Insights and Forecast,  2017-2032
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Portable PFT Systems
  12.4.2 Complete PFT Systems
 12.5 Historic and Forecasted Market Size By Test
  12.5.1 Gas Exchange Testing
  12.5.2 Oxygen Titration Test
  12.5.3 Spirometry
  12.5.4 Lung Volume
  12.5.5 Others
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Restrictive Lung Disease
  12.6.2 Chronic Obstructive Pulmonary Disease
  12.6.3 Asthma
  12.6.4 Other
 12.7 Historic and Forecasted Market Size By End Users
  12.7.1 Hospitals
  12.7.2 Clinical Laboratories
  12.7.3 Diagnostics Laboratories
  12.7.4 Other
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Pulmonary Function Testing Systems Market Analysis, Insights and Forecast,  2017-2032
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Portable PFT Systems
  13.4.2 Complete PFT Systems
 13.5 Historic and Forecasted Market Size By Test
  13.5.1 Gas Exchange Testing
  13.5.2 Oxygen Titration Test
  13.5.3 Spirometry
  13.5.4 Lung Volume
  13.5.5 Others
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Restrictive Lung Disease
  13.6.2 Chronic Obstructive Pulmonary Disease
  13.6.3 Asthma
  13.6.4 Other
 13.7 Historic and Forecasted Market Size By End Users
  13.7.1 Hospitals
  13.7.2 Clinical Laboratories
  13.7.3 Diagnostics Laboratories
  13.7.4 Other
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Pulmonary Function Testing Systems Market Analysis, Insights and Forecast,  2017-2032
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Portable PFT Systems
  14.4.2 Complete PFT Systems
 14.5 Historic and Forecasted Market Size By Test
  14.5.1 Gas Exchange Testing
  14.5.2 Oxygen Titration Test
  14.5.3 Spirometry
  14.5.4 Lung Volume
  14.5.5 Others
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Restrictive Lung Disease
  14.6.2 Chronic Obstructive Pulmonary Disease
  14.6.3 Asthma
  14.6.4 Other
 14.7 Historic and Forecasted Market Size By End Users
  14.7.1 Hospitals
  14.7.2 Clinical Laboratories
  14.7.3 Diagnostics Laboratories
  14.7.4 Other
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Pulmonary Function Testing Systems Market Analysis, Insights and Forecast,  2017-2032
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Portable PFT Systems
  15.4.2 Complete PFT Systems
 15.5 Historic and Forecasted Market Size By Test
  15.5.1 Gas Exchange Testing
  15.5.2 Oxygen Titration Test
  15.5.3 Spirometry
  15.5.4 Lung Volume
  15.5.5 Others
 15.6 Historic and Forecasted Market Size By Application
  15.6.1 Restrictive Lung Disease
  15.6.2 Chronic Obstructive Pulmonary Disease
  15.6.3 Asthma
  15.6.4 Other
 15.7 Historic and Forecasted Market Size By End Users
  15.7.1 Hospitals
  15.7.2 Clinical Laboratories
  15.7.3 Diagnostics Laboratories
  15.7.4 Other
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PULMONARY FUNCTION TESTING SYSTEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PULMONARY FUNCTION TESTING SYSTEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PULMONARY FUNCTION TESTING SYSTEMS MARKET COMPETITIVE RIVALRY
TABLE 005. PULMONARY FUNCTION TESTING SYSTEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. PULMONARY FUNCTION TESTING SYSTEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY TYPE
TABLE 008. PORTABLE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. COMPLETE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 010. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY TEST
TABLE 011. GAS EXCHANGE TESTING MARKET OVERVIEW (2016-2028)
TABLE 012. OXYGEN TITRATION TEST MARKET OVERVIEW (2016-2028)
TABLE 013. SPIROMETRY MARKET OVERVIEW (2016-2028)
TABLE 014. LUNG VOLUME MARKET OVERVIEW (2016-2028)
TABLE 015. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 016. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY APPLICATION
TABLE 017. RESTRICTIVE LUNG DISEASE MARKET OVERVIEW (2016-2028)
TABLE 018. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
TABLE 019. ASTHMA MARKET OVERVIEW (2016-2028)
TABLE 020. OTHER MARKET OVERVIEW (2016-2028)
TABLE 021. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY END USERS
TABLE 022. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 023. CLINICAL LABORATORIES MARKET OVERVIEW (2016-2028)
TABLE 024. DIAGNOSTICS LABORATORIES MARKET OVERVIEW (2016-2028)
TABLE 025. OTHER MARKET OVERVIEW (2016-2028)
TABLE 026. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 027. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST (2016-2028)
TABLE 028. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 029. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY END USERS (2016-2028)
TABLE 030. N PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 031. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 032. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST (2016-2028)
TABLE 033. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 034. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY END USERS (2016-2028)
TABLE 035. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 036. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 037. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST (2016-2028)
TABLE 038. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 039. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY END USERS (2016-2028)
TABLE 040. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY END USERS (2016-2028)
TABLE 045. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 046. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 047. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST (2016-2028)
TABLE 048. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 049. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY END USERS (2016-2028)
TABLE 050. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 051. MGC DIAGNOSTICS CORPORATION: SNAPSHOT
TABLE 052. MGC DIAGNOSTICS CORPORATION: BUSINESS PERFORMANCE
TABLE 053. MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO
TABLE 054. MGC DIAGNOSTICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. MORGAN SCIENTIFIC INC.: SNAPSHOT
TABLE 055. MORGAN SCIENTIFIC INC.: BUSINESS PERFORMANCE
TABLE 056. MORGAN SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 057. MORGAN SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. OMRON HEALTHCARE INC: SNAPSHOT
TABLE 058. OMRON HEALTHCARE INC: BUSINESS PERFORMANCE
TABLE 059. OMRON HEALTHCARE INC: PRODUCT PORTFOLIO
TABLE 060. OMRON HEALTHCARE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. COSMED SRL: SNAPSHOT
TABLE 061. COSMED SRL: BUSINESS PERFORMANCE
TABLE 062. COSMED SRL: PRODUCT PORTFOLIO
TABLE 063. COSMED SRL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. GANSHORN MEDIZIN ELECTRONIC: SNAPSHOT
TABLE 064. GANSHORN MEDIZIN ELECTRONIC: BUSINESS PERFORMANCE
TABLE 065. GANSHORN MEDIZIN ELECTRONIC: PRODUCT PORTFOLIO
TABLE 066. GANSHORN MEDIZIN ELECTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. NDD MEDIZINTECHNIK AG: SNAPSHOT
TABLE 067. NDD MEDIZINTECHNIK AG: BUSINESS PERFORMANCE
TABLE 068. NDD MEDIZINTECHNIK AG: PRODUCT PORTFOLIO
TABLE 069. NDD MEDIZINTECHNIK AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. SCHILLER AG: SNAPSHOT
TABLE 070. SCHILLER AG: BUSINESS PERFORMANCE
TABLE 071. SCHILLER AG: PRODUCT PORTFOLIO
TABLE 072. SCHILLER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. VYAIRE MEDICAL INC: SNAPSHOT
TABLE 073. VYAIRE MEDICAL INC: BUSINESS PERFORMANCE
TABLE 074. VYAIRE MEDICAL INC: PRODUCT PORTFOLIO
TABLE 075. VYAIRE MEDICAL INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. MINATO HOLDINGS INC.: SNAPSHOT
TABLE 076. MINATO HOLDINGS INC.: BUSINESS PERFORMANCE
TABLE 077. MINATO HOLDINGS INC.: PRODUCT PORTFOLIO
TABLE 078. MINATO HOLDINGS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. ECO MEDICS AG: SNAPSHOT
TABLE 079. ECO MEDICS AG: BUSINESS PERFORMANCE
TABLE 080. ECO MEDICS AG: PRODUCT PORTFOLIO
TABLE 081. ECO MEDICS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. CHEST M.I. INC: SNAPSHOT
TABLE 082. CHEST M.I. INC: BUSINESS PERFORMANCE
TABLE 083. CHEST M.I. INC: PRODUCT PORTFOLIO
TABLE 084. CHEST M.I. INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. KONINKLIJKE PHILIPS N.V.: SNAPSHOT
TABLE 085. KONINKLIJKE PHILIPS N.V.: BUSINESS PERFORMANCE
TABLE 086. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 087. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. PULMONE ADVANCED MEDICAL DEVICES: SNAPSHOT
TABLE 088. PULMONE ADVANCED MEDICAL DEVICES: BUSINESS PERFORMANCE
TABLE 089. PULMONE ADVANCED MEDICAL DEVICES: PRODUCT PORTFOLIO
TABLE 090. PULMONE ADVANCED MEDICAL DEVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. KOKO PFT: SNAPSHOT
TABLE 091. KOKO PFT: BUSINESS PERFORMANCE
TABLE 092. KOKO PFT: PRODUCT PORTFOLIO
TABLE 093. KOKO PFT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 094. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 095. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 096. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY TYPE
FIGURE 012. PORTABLE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. COMPLETE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY TEST
FIGURE 015. GAS EXCHANGE TESTING MARKET OVERVIEW (2016-2028)
FIGURE 016. OXYGEN TITRATION TEST MARKET OVERVIEW (2016-2028)
FIGURE 017. SPIROMETRY MARKET OVERVIEW (2016-2028)
FIGURE 018. LUNG VOLUME MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 020. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY APPLICATION
FIGURE 021. RESTRICTIVE LUNG DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 022. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 023. ASTHMA MARKET OVERVIEW (2016-2028)
FIGURE 024. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 025. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY END USERS
FIGURE 026. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 027. CLINICAL LABORATORIES MARKET OVERVIEW (2016-2028)
FIGURE 028. DIAGNOSTICS LABORATORIES MARKET OVERVIEW (2016-2028)
FIGURE 029. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 030. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)